S-Space

Browse

Author

Jump to a point in the index

Or type in a year

Sort by
In order
Results/Page
Authors/record

Showing results 61 to 120 of 215

Issue Date	Title / Author(s) / Citation	File
2009-08	Combination chemotherapy with capecitabine and cisplatin for patients with metastatic hepatocellular carcinoma Lee, J. O.; Lee, K. W.; Oh, D. Y.; Kim, J. H.; Im, S. A.; Kim, T. Y.; Bang, Y. J. Annals of Oncology, Vol.20 No.8, pp.1402-1407	DOI
2009-09	Results of breast-conserving therapy for multifocal or multicentric breast cancers Chie, Eui Kyu; Kim, Kyubo; Han, Wonshik; Noh, Dong-Young; Oh, Do-Youn; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue; Ha, Sung W. Asia-Pacific Journal of Clinical Oncology, Vol.5 No.3, pp.200-205	DOI
2009-09	Risk factors for poor treatment outcome and central nervous system relapse in diffuse large B-cell lymphoma with bone marrow involvement Lee, Keun-Wook; Yi, Jongyoun; Choi, In Sil; Kim, Jee Hyun; Bang, Soo-Mee; Kim, Dong-Wan; Im, Seock-Ah; Kim, Tae-You; Yoon, Sung-Soo; Lee, Jong Seok; Bang, Yung-Jue; Park, Seonyang; Kim, Byoung Kook; Cho, Han Ik; Heo, Dae Seog Annals of Hematology, Vol.88 No.9, pp.829-838	DOI
2009-09	Combination of EGFR and MEK1/2 inhibitor shows synergistic effects by suppressing EGFR/HER3-dependent AKT activation in human gastric cancer cells Yoon, Young-Kwang; Kim, Hwang-Phill; Han, Sae-Won; Hur, Hyung-Seok; Oh, Do Youn; Im, Seock-Ah; Bang, Yung-Jue; Kim, Tae-You Molecular Cancer Therapeutics, Vol.8 No.9, pp.2526-2536	DOI
2009-09	Adjuvant concurrent chemoradiation therapy (CCRT) alone versus CCRT followed by adjuvant chemotherapy: Which is better in patients with radically resected extrahepatic biliary tract cancer?: a non-randomized, single center study Lim, Kyu-Hyoung; Oh, Do-Youn; Chie, Eui Kyu; Jang, Jin-Young; Im, Seock-Ah; Kim, Tae-You; Kim, Sun-Whe; Ha, Sung Whan; Bang, Yung-Jue BMC Cancer, Vol.9 No.1, p. 345	DOI
2009-10	Weekly Paclitaxel and Trastuzumab as a First-Line Therapy in Patients with HER2-Overexpressing Metastatic Breast Cancer: Magnitude of HER2/neu Amplification as a Predictive Factor for Efficacy Han, Hye-Suk; Kim, Jin-Soo; Park, Jin Hyun; Jeon, Yoon Kyung; Lee, Keun-Wook; Oh, Do-Youn; Kim, Jee Hyun; Park, So Yeon; Im, Seock-Ah; Kim, Tae-You; Park, In Ae; Bang, Yung-Jue Journal of Korean Medical Science, Vol.24 No.5, pp.910-917	view file DOI
2009-10	Role of Adjuvant Chemoradiotherapy for Ampulla of Vater Cancer Kim, Kyubo; Chie, Eui Kyu; Jang, Jin-Young; Kim, Sun Whe; Oh, Do-Youn; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue; Ha, Sung W. International Journal of Radiation Oncology Biology Physics, Vol.75 No.2, pp.436-441	DOI
2010-02	Prognostic Value of p53 and bcl-2 Expression in Patients Treated with Breast Conservative Therapy Kim, Kyubo; Chie, Eui Kyu; Han, Wonshik; Noh, Dong-Young; Park, In Ae; Oh, Do-Youn; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue; Ha, Sung W. Journal of Korean Medical Science, Vol.25 No.2, pp.235-239	view file DOI
2010-02	Prognostic Factors Affecting the Outcome of Salvage Radiotherapy for Isolated Locoregional Recurrence After Mastectomy Kim, Kyubo; Chie, Eui Kyu; Han, Wonshik; Noh, Dong-Young; Oh, Do-Youn; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue; Ha, Sung W. American Journal of Clinical Oncology, Vol.33 No.1, pp.23-27	DOI
2010-02	Metaplastic Breast Carcinoma: Clinicopathologic Features and Prognostic Value of Triple Negativity Lim, Kyu-Hyoung; Oh, Do-Youn; Chie, Eui Kyu; Han, Wonshik; Im, Seock-Ah; Kim, Tae-You; Park, In Ae; Noh, Dong-Young; Ha, Sung Whan; Bang, Yung-Jue Japanese Journal of Clinical Oncology, Vol.40 No.2, pp.112-118	DOI
2010-03	Epidermal growth factor receptor intron 1 CA dinucleotide repeat polymorphism and survival of advanced gastric cancer patients treated with cetuximab plus modified FOLFOX6 Han, Sae-Won; Oh, Do-Youn; Im, Seock-Ah; Park, Sook Ryun; Lee, Keun-Wook; Song, Hong Suk; Lee, Nam-Su; Lee, Kyung Hee; Choi, In Sil; Lee, Moon Hee; Kim, Min A.; Kim, Woo Ho; Bang, Yung-Jue; Kim, Tae-You Cancer Science, Vol.101 No.3, pp.793-799	DOI
2010-03	Expression of Class III Beta-Tubulin Correlates with Unfavorable Survival Outcome in Patients with Resected Non-small Cell Lung Cancer Koh, Youngil; Jang, Bogun; Han, Sae-Won; Kim, Tae-Min; Oh, Do-Youn; Lee, Se-Hoon; Kang, Chang Hyun; Kim, Dong-Wan; Im, Seock-Ah; Chung, Doo Hyun; Kim, Young Tae; Kim, Tae-You; Kim, Young-Whan; Kim, Joo Hyun; Heo, Dae Seog; Bang, Yung-Jue Journal of Thoracic Oncology, Vol.5 No.3, pp.320-325	DOI
2010-04	KRAS Mutant Lung Cancer Cells Are Differentially Responsive to MEK Inhibitor Due to AKT or STAT3 Activation: Implication for Combinatorial Approach Yoon, Young-Kwang; Kim, Hwang-Phill; Han, Sae-Won; Oh, Do Youn; Im, Seock-Ah; Bang, Yung-Jue; Kim, Tae-You Molecular Carcinogenesis, Vol.49 No.4, pp.353-362	DOI
2010-06	DNA methyltransferase 3-like affects promoter methylation of thymine DNA glycosylase independently of DNMT1 and DNMT3B in cancer cells Kim, Heesun; Park, Jinah; Jung, Yeonjoo; Song, Sang-Hyun; Han, Sae-Won; Oh, Do-Youn; Im, Seock-Ah; Bang, Yung-Jue; Kim, Tae-You International Journal of Oncology, Vol.36 No.6, pp.1563-1572	DOI
2010-06	The relationship between response to previous systemic treatment and the efficacy of subsequent pemetrexed therapy in advanced non-small cell lung cancer Sun, Jong-Mu; Oh, Do-Youn; Lee, Se-Hoon; Kim, Dong-Wan; Im, Seock-Ah; Kim, Tae-You; Lee, Jong Seok; Kim, Young-Whan; Heo, Dae Seog; Bang, Yung-Jue Lung Cancer, Vol.68 No.3, pp.427-432	DOI
2010-06	Prognostic factors for recurrent breast cancer patients with an isolated, limited number of lung metastases and implications for pulmonary metastasectomy Yhim, Ho-Young; Han, Sae-Won; Oh, Do-Youn; Han, Wonshik; Im, Seock-Ah; Kim, Tae-You; Kim, Young Tae; Noh, Dong-Young; Chie, Eui Kyu; Ha, Sung Whan; Park, In Ae; Bang, Yung-Jue Cancer, Vol.116 No.12, pp.2890-2901	DOI
2010-08	Biological characteristics and treatment outcomes of metastatic or recurrent neuroendocrine tumors: tumor grade and metastatic site are important for treatment strategy Kim, Su-Jung; Kim, Jin Won; Han, Sae-Won; Oh, Do-Youn; Lee, Se-Hoon; Kim, Dong-Wan; Im, Seock-Ah; Kim, Tae-You; Heo, Dae Seog; Bang, Yung-Jue BMC Cancer, Vol.10, p. 448	view file DOI
2010-09	Clinicopathologic features and clinical outcomes of gastric cancer that initially presents with disseminated intravascular coagulation: A retrospective study Rhee, Jiyoung; Han, Sae-Won; Oh, Do-Youn; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue Journal of Gastroenterology and Hepatology, Vol.25 No.9, pp.1537-1542	DOI
2010-10	Triple negativity and young age as prognostic factors in lymph node-negative invasive ductal carcinoma of 1 cm or less Kwon, Ji Hyun; Kim, Yu Jung; Lee, Keun-Wook; Oh, Do-Youn; Park, So Yeon; Kim, Jee Hyun; Chie, Eui Kyu; Kim, Sung-Won; Im, Seock-Ah; Kim, In-Ah; Kim, Tae-You; Park, In Ae; Noh, Dong-Young; Bang, Yung-Jue; Ha, Sung Whan BMC Cancer, Vol.10, p. 557	view file DOI
2010-12	Combination Chemotherapy with S-1 and Platinum in Advanced Hepatocellular Carcinoma Kim, Su-Jung; Han, Sae-Won; Oh, Do-Youn; Yi, Nam-Joon; Kim, Yoon Jun; Im, Seock-Ah; Yoon, Jung-Hwan; Kang, Gyeong Hoon; Suh, Kyung Suk; Bang, Yung-Jue; Jang, Ja-Joon; Kim, Tae-You Anticancer Research, Vol.30 No.12, pp.5245-5250
2010-12	RAD001 shows activity against gastric cancer cells and overcomes 5-FU resistance by downregulating thymidylate synthase Lee, Kyung-Hun; Hur, Hyung-Seok; Im, Seock-Ah; Lee, Juhee; Kim, Hwang-Phill; Yoon, Young-Kwang; Han, Sae-Won; Song, Sang-Hyun; Oh, Do-Youn; Kim, Tae-You; Bang, Yung-Jue Cancer Letters, Vol.299 No.1, pp.22-28	DOI
2011-01	High serum TGF-alpha predicts poor response to lapatinib and capecitabine in HER2-positive breast cancer Rhee, Jiyoung; Han, Sae-Won; Cha, Yongjun; Ham, Hye Seon; Kim, Hwang-phill; Oh, Do-Youn; Im, Seock-Ah; Park, Jong-Wan; Ro, Jungsil; Lee, Keun Seok; Park, In Hae; Im, Young-Hyuck; Bang, Yung-Jue; Kim, Tae-You Breast Cancer Research and Treatment, Vol.125 No.1, pp.107-114	DOI
2011-01	Age < 40 Years is an Independent Prognostic Factor Predicting Inferior Overall Survival in Patients Treated with Breast Conservative Therapy Kim, Kyubo; Chie, Eui Kyu; Han, Wonshik; Noh, Dong-Young; Oh, Do-Youn; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue; Ha, Sung W. Breast Journal, Vol.17 No.1, pp.75-78	DOI
2011-02	Increasing Nodal Ratio is a Poor Prognostic Factor for Survival in Stage III-IV (M0) Gastric Cancer Patients Who Received Curative Surgery Followed by Adjuvant Chemotherapy: A Retrospective Study Kim, Jin-Soo; Kim, Min-A; Oh, Do-Youn; Lee, Se-Hoon; Kim, Dong-Wan; Im, Seock-Ah; Kim, Woo Ho; Yang, Han-Kwang; Heo, Dae Seog; Bang, Yung-Jue; Lee, Kuhn-Uk; Kim, Tae-You Japanese Journal of Clinical Oncology, Vol.41 No.2, pp.245-252	DOI
2011-03	Ki-67 can be used for further classification of triple negative breast cancer into two subtypes with different response and prognosis Keam, Bhumsuk; Im, Seock-Ah; Lee, Kyung-Hun; Han, Sae-Won; Oh, Do-Youn; Kim, Jee Hyun; Lee, Se-Hoon; Han, Wonshik; Kim, Dong-Wan; Kim, Tae-You; Park, In Ae; Noh, Dong-Young; Heo, Dae Seog; Bang, Yung-Jue Breast Cancer Research, Vol.13 No.2, p. R22	view file DOI
2011-03	Antitumor activity of HM781-36B, an irreversible Pan-HER inhibitor, alone or in combination with cytotoxic chemotherapeutic agents in gastric cancer Nam, Hyun-Jin; Kim, Hwang-Phill; Yoon, Young-Kwang; Hur, Hyung-Seok; Song, Sang-Hyun; Kim, Maeng-Sup; Lee, Gwan-Sun; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Oh, Do-Youn; Bang, Yung-Jue Cancer Letters, Vol.302 No.2, pp.155-165	DOI
2011-04	Clinical Outcomes of Sorafenib Treatment in Patients With Metastatic Hepatocellular Carcinoma Who Had Been Previously Treated With Fluoropyrimidine Plus Platinum-based Chemotherapy Kim, Ji-Won; Lee, Jeong-Ok; Han, Sae-Won; Oh, Do-Youn; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue American Journal of Clinical Oncology, Vol.34 No.2, pp.125-129	DOI
2011-04	The value of preoperative staging chest computed tomography to detect asymptomatic lung and liver metastasis in patients with primary breast carcinoma Kim, Hyeyoung; Han, Wonshik; Moon, Hyeong-Gon; Min, Junwon; Ahn, Soo-Kyung; Kim, Tae-You; Im, Seock-Ah; Oh, Do-Youn; Han, Sae-Won; Chie, Eui Kyu; Ha, Sung Whan; Noh, Dong-Young Breast Cancer Research and Treatment, Vol.126 No.3, pp.637-641	DOI
2011-05	Discordant human epidermal growth factor receptor 2 and hormone receptor status in primary and metastatic breast cancer and response to trastuzumab Chang, Hye Jung; Han, Sae-Won; Oh, Do-Youn; Im, Seock-Ah; Jeon, Yoon Kyung; Park, In Ae; Han, Wonshick; Noh, Dong-Young; Bang, Yung-Jue; Kim, Tae-You Japanese Journal of Clinical Oncology, Vol.41 No.5, pp.593-599	DOI
2011-05	Clinicopathologic characteristics and treatment outcomes of hepatoid adenocarcinoma of the stomach, a rare but unique subtype of gastric cancer Baek, Sun Kyung; Han, Sae-Won; Oh, Do-Youn; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue BMC Gastroenterology, Vol.11, p. 56	DOI
2011-05	Diagnostic performance of contrast enhanced CT and 18F-FDG PET/CT in suspicious recurrence of biliary tract cancer after curative resection Lee, Yun-Gyoo; Han, Sae-Won; Oh, Do-Youn; Chie, Eui Kyu; Jang, Jin-Young; Im, Seock-Ah; Kim, Tae-You; Kim, Sun-Whe; Ha, Sung Whan; Bang, Yung-Jue BMC Cancer, Vol.11, p. 188	DOI
2011-06	Phase II study of biweekly S-1 and oxaliplatin combination chemotherapy in metastatic colorectal cancer and pharmacogenetic analysis Hong, Junshik; Han, Sae-Won; Ham, Hye Seon; Kim, Tae-Yong; Choi, In Sil; Kim, Byung-Su; Oh, Do-Youn; Im, Seock-Ah; Kang, Gyeong Hoon; Bang, Yung-Jue; Kim, Tae-You Cancer Chemotherapy and Pharmacology, Vol.67 No.6, pp.1323-1331	DOI
2011-06	Clinicopathologic characteristics of patients with stage III/IV (M 0) advanced gastric cancer, according to HER2 status assessed by immunohistochemistry and fluorescence in situ hybridization Im, Seock-Ah; Kim, Jin Won; Kim, Jin-Soo; Kim, Min A.; Jordan, Bruce; Pickl, Marlene; Han, Sae-Won; Oh, Do-Youn; Lee, Hyuk Joon; Kim, Tae-You; Kim, Woo Ho; Yang, Han-Kwang; Bang, Yung-Jue Diagnostic Molecular Pathology, Vol.20 No.2, pp.94-100	DOI
2011-07	Antitumor activity of NVP-AUY922, a novel heat shock protein 90 inhibitor, in human gastric cancer cells is mediated through proteasomal degradation of client proteins Lee, Kyung-Hun; Lee, Ju-Hee; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Oh, Do-Youn; Bang, Yung-Jue Cancer Science, Vol.102 No.7, pp.1388-1395	DOI
2011-07	Prognostic implication of 18F FDG-PET in patients with extrahepatic metastatic hepatocellular carcinoma undergoing systemic treatment, a retrospective cohort study Shin, Dong-Yeop; Han, Sae-Won; Oh, Do-Youn; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue Cancer Chemotherapy and Pharmacology, Vol.68 No.1, pp.165-175	DOI
2011-09	Nomogram predicting clinical outcomes in breast cancer patients treated with neoadjuvant chemotherapy Keam, Bhumsuk; Im, Seock-Ah; Park, Sohee; Nam, Byung-Ho; Han, Sae-Won; Oh, Do-Youn; Kim, Jee Hyun; Lee, Se-Hoon; Han, Wonshik; Kim, Dong-Wan; Kim, Tae-You; Park, In Ae; Noh, Dong-Young; Heo, Dae Seog; Bang, Yung-Jue Journal of Cancer Research and Clinical Oncology, Vol.137 No.9, pp.1301-1308	DOI
2011-09	VEGF Expression is Related to Good Response and Long Progression-free Survival in Gastrointestinal Stromal Tumor Patients Treated With Sunitinib Koh, Youngil; Lee, Hee Eun; Im, Seock-Ah; Kim, Se-Hyung; Kim, Tae Min; Han, Sae-Won; Oh, Do-Youn; Kim, Jee Hyun; Lee, Se-Hoon; Kim, Dong-Wan; Kim, Tae-You; Kim, Woo-Ho; Heo, Dae Seog; Bang, Yung-Jue Diagnostic Molecular Pathology, Vol.20 No.3, pp.143-147	DOI
2011-09	17p12 deletion in breast cancer predicts resistance to neoadjuvant chemotherapy Han, Wonshik; Woo, Jung Hoon; Jeon, Yoon Kyung; Yang, Song-Ju; Cho, Jihyoung; Ko, Eunyoung; Kim, Tae-You; Im, Seock-Ah; Oh, Do-Youn; Park, In-Ae; Hwang, Ki-Tae; Moon, Hyeong-Gon; Yang, Kap-Seok; Noh, Dung-Young Experimental and Therapeutic Medicine, Vol.2 No.5, pp.799-804	DOI
2011-10	Analysis of KRAS, BRAF, PTEN, IGF1R, EGFR intron 1 CA status in both primary tumors and paired metastases in determining benefit from cetuximab therapy in colon cancer Park, Jin Hyun; Han, Sae-Won; Oh, Do-Youn; Im, Seock-Ah; Jeong, Seung-Yong; Park, Kyu Joo; Kim, Tae-You; Bang, Yung-Jue; Park, Jae-Gahb Cancer Chemotherapy and Pharmacology, Vol.68 No.4, pp.1045-1055	DOI
2011-10	Efficacy of infusional 5-fluorouracil, doxorubicin, and mitomycin-C (iFAM) in the treatment of patients with gemcitabine-pretreated pancreatic cancer and analysis of prognostic factors in a salvage setting Lim, Kyu-Hyoung; Kim, Tae-Yong; Lee, Kyung-Hun; Han, Sae-Won; Oh, Do-Youn; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue Cancer Chemotherapy and Pharmacology, Vol.68 No.4, pp.1017-1026	DOI
2011-10	Early metabolic response using FDG PET/CT and molecular phenotypes of breast cancer treated with neoadjuvant chemotherapy Keam, Bhumsuk; Im, Seock-Ah; Koh, Youngil; Han, Sae-Won; Oh, Do-Youn; Cho, Nariya; Kim, Jee Hyun; Han, Wonshik; Kang, Keon Wook; Moon, Woo Kyung; Kim, Tae-You; Park, In Ae; Noh, Dong-Young; Chung, June-Key; Bang, Yung-Jue BMC Cancer, Vol.11, p. 452	DOI
2012-01	Clinical outcome of central nervous system metastases from breast cancer: differences in survival depending on systemic treatment Kim, Hee-Jun; Im, Seock-Ah; Keam, Bhumsuk; Kim, Yu-Jung; Han, Sae-Won; Kim, Tae Min; Oh, Do-Youn; Kim, Jee Hyun; Lee, Se-Hoon; Chie, Eui Kyu; Han, Wonshik; Kim, Dong-Wan; Kim, Tae-You; Noh, Dong-Young; Heo, Dae Seog; Park, In Ae; Bang, Yung-Jue; Ha, Sung Whan Journal of Neuro-Oncology, Vol.106 No.2, pp.303-313	DOI
2012-02	Evaluation of the Antitumor Effects and Mechanisms of PF00299804, a Pan-HER Inhibitor, Alone or in Combination with Chemotherapy or Targeted Agents in Gastric Cancer Nam, Hyun-Jin; Ching, Keith A.; Kan, Julie; Kim, Hwang-Phill; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Christensen, James G.; Oh, Do-Youn; Bang, Yung-Jue Molecular Cancer Therapeutics, Vol.11 No.2, pp.439-451	DOI
2012-02	Association of oral mucositis with quality of life and symptom clusters in patients with solid tumors receiving chemotherapy Kim, Jin Won; Cha, Yongjun; Kim, Su-Jung; Han, Sae-Won; Oh, Do-Youn; Lee, Se-Hoon; Kim, Dong-Wan; Im, Seock-Ah; Kim, Tae-You; Heo, Dae Seog; Bang, Yung-Jue Supportive Care in Cancer, Vol.20 No.2, pp.395-403	DOI
2012-03	Antitumor activity of HM781-36B, a pan-HER tyrosine kinase inhibitor, in HER2-amplified breast cancer cells Kim, Hye Jin; Kim, Hwang-Phill; Yoon, Young-Kwang; Kim, Maeng-Sup; Lee, Gwan-Sun; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Oh, Do-Youn; Bang, Yung-Jue Anti-Cancer Drugs, Vol.23 No.3, pp.288-297	DOI
2012-03	Down-regulation of mitogen-inducible gene 6, a negative regulator of EGFR, enhances resistance to MEK inhibition in KRAS mutant cancer cells Yoon, Young-Kwang; Kim, Hwang-Phill; Song, Sang-Hyun; Han, Sae-Won; Oh, Do Youn; Im, Seock-Ah; Bang, Yung-Jue; Kim, Tae-You Cancer Letters, Vol.316 No.1, pp.77-84	DOI
2012-03	Heterodimerization of glycosylated insulin-like growth factor-1 receptors and insulin receptors in cancer cells sensitive to anti-IGF1R antibody Kim, Jun Gyu; Kang, Min Jueng; Yoon, Young-Kwang; Kim, Hwang-Phill; Park, Jinah; Song, Sang-Hyun; Han, Sae-Won; Park, Jong-Wan; Kang, Gyeong Hoon; Kang, Keon Wook; Oh, Do Youn; Im, Seock-Ah; Bang, Yung-Jue; Yi, Eugene C.; Kim, Tae-You PLoS ONE, Vol.7 No.3, p. e0033322	DOI
2012-04	Adjuvant chemoradiotherapy after curative resection for extrahepatic bile duct cancer: A long-term single center experience Kim, Kyubo; Chie, Eui Kyu; Jang, Jin-Young; Kim, Sun Whe; Han, Sae-Won; Oh, Do-Youn; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue; Ha, Sung W. American Journal of Clinical Oncology, Vol.35 No.2, pp.136-140	DOI
2012-04	NVP-BKM120, a novel PI3K inhibitor, shows synergism with a STAT3 inhibitor in human gastric cancer cells harboring KRAS mutations Park, Eunju; Park, Jinah; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Oh, Do-Youn; Bang, Yung-Jue International Journal of Oncology, Vol.40 No.4, pp.1259-1266	DOI
2012-04	The Prognostic Significance of HER2 Positivity for Advanced Gastric Cancer Patients Undergoing First-line Modified FOLFOX-6 Regimen Kim, Jin Won; Im, Seock-Ah; Kim, Miso; Cha, Yongjun; Lee, Kyung-Hun; Keam, Bhumsuk; Kim, Min A.; Han, Sae-Won; Oh, Do-Youn; Kim, Tae-You; Kim, Woo Ho; Bang, Yung-Jue Anticancer Research, Vol.32 No.4, pp.1547-1553
2012-05	Postoperative chemoradiotherapy for gallbladder cancer Kim, K.; Chie, E. K.; Jang, J. -Y.; Kim, S. W.; Han, S. -W.; Oh, D. -Y.; Im, S. -A.; Kim, T. -Y.; Bang, Y. -J.; Ha, S. W. Strahlentherapie und Onkologie, Vol.188 No.5, pp.388-394	DOI
2012-05	Prognostic significance of tumour location after adjuvant chemoradiotherapy for periampullary adenocarcinoma Kim, Kyubo; Chie, Eui Kyu; Jang, Jin-Young; Kim, Sun Whe; Han, Sae-Won; Oh, Do-Youn; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue; Ha, Sung W. Clinical and Translational Oncology, Vol.14 No.5, pp.391-395	DOI
2012-07	Gene silencing of EREG mediated by DNA methylation and histone modification in human gastric cancers Yun, Jiyeon; Song, Sang-Hyun; Park, Jinah; Kim, Hwang-Phill; Yoon, Young-Kwang; Lee, Kyung-Hun; Han, Sae-Won; Oh, Do-Youn; Im, Seock-Ah; Bang, Yung-Jue; Kim, Tae-You Laboratory Investigation, Vol.92 No.7, pp.1033-1044	DOI
2012-07	Breast density change as a predictive surrogate for response to adjuvant endocrine therapy in hormone receptor positive breast cancer Kim, Jisun; Han, Wonshik; Moon, Hyeong-Gon; Ahn, Soo Kyung; Shin, Hee-Chul; You, Jee-Man; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Koo, Hye Ryoung; Chang, Jung Min; Cho, Nariya; Moon, Woo Kyung; Noh, Dong-Young Breast Cancer Research, Vol.14 No.4, p. R102	view file DOI
2012-07	Outcome of Infusional 5-Fluorouracil, Doxorubicin, and Mitomycin-C (iFAM) Chemotherapy and Analysis of Prognostic Factors in Patients with Refractory Advanced Biliary Tract Cancer Lim, Kyu-Hyoung; Han, Sae-Won; Oh, Do-Youn; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue Oncology, Vol.83 No.2, pp.57-66	DOI
2012-07	Correlation of HER2, p95HER2 and HER3 expression and treatment outcome of lapatinib plus capecitabine in HER2-positive metastatic breast cancer Han, Sae-Won; Cha, Yongjun; Paquet, Agnes; Huang, Weidong; Weidler, Jodi; Lie, Yolanda; Sherwood, Thomas; Bates, Michael; Haddad, Mojgan; Park, In Hae; Oh, Do-Youn; Lee, Keun Seok; Im, Seock-Ah; Bang, Yung-Jue; Ro, Jungsil; Kim, Tae-You PLoS ONE, Vol.7 No.7, p. e0039943	DOI
2012-08	ABCB1, FCGR2A, and FCGR3A Polymorphisms in Patients with HER2-Positive Metastatic Breast Cancer Who Were Treated with First-Line Taxane plus Trastuzumab Chemotherapy Kim, Ji-Won; Kim, Jee Hyun; Im, Seock-Ah; Kim, Yu Jung; Han, Hye-Suk; Kim, Jin-Soo; Han, Sae-Won; Jeon, Yoon Kyung; Oh, Do-Youn; Han, Wonshik; Kim, Tae-You; Park, In Ae; Noh, Dong-Young; Bang, Yung-Jue Oncology, Vol.83 No.4, pp.218-227	DOI
2012-08	Down-regulation of P-cadherin with PF-03732010 inhibits cell migration and tumor growth in gastric cancer Park, Jinah; Park, Eunju; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Kim, Woo-Ho; Oh, Do-Youn; Bang, Yung-Jue Investigational New Drugs, Vol.30 No.4, pp.1404-1412	DOI
2012-08	Sunitinib synergizes the antitumor effect of cisplatin via modulation of ERCC1 expression in models of gastric cancer Yoon, Young-Kwang; Im, Seock-Ah; Min, Ahrum; Kim, Hwang-Phill; Hur, Hyung-Seok; Lee, Kyung-Hun; Han, Sae-Won; Song, Sang-Hyun; Oh, Do Youn; Kim, Tae-You; Kim, Woo Ho; Bang, Yung-Jue Cancer Letters, Vol.321 No.2, pp.128-136	DOI
2012-09	Phase II clinical trial of induction chemotherapy with fixed dose rate gemcitabine and cisplatin followed by concurrent chemoradiotherapy with capecitabine for locally advanced pancreatic cancer Kim, Jae-Sung; Lim, Joo Han; Kim, Jee Hyun; Im, Seock-Ah; Chie, Eui Kyu; Hwang, Jin-Hyeok; Kim, Tae-You; Bang, Yung-Jue; Ha, Sung Whan; Yoon, Yong Bum Cancer Chemotherapy and Pharmacology, Vol.70 No.3, pp.381-389	DOI

1 2 3 4